Bryan MacDonald

Dr. Bryan MacDonald

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Heart Rhythm
Verified
Journal Article
Closed access
SMSanghamitra Mohanty
Sanghamitra Mohanty
CGCarola Gianni
Carola Gianni
CTChintan Trivedi
Chintan Trivedi
VGVaruna Gadiyaram
Varuna Gadiyaram
DRDomenico Giovanni. Della Rocca
Domenico Giovanni. Della Rocca
ANAndrea Natale
Andrea Natale

1 June 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SMSanghamitra Mohanty
Sanghamitra Mohanty
CTChintan Trivedi
Chintan Trivedi
PHPamela Horton
Pamela Horton
DRDomenico G. Della Rocca
Domenico G. Della Rocca
CGCarola Gianni
Carola Gianni
ANAndrea Natale
Andrea Natale
Background: We evaluated long‐term outcome of isolation of pulmonary veins, left atrial posterior wall, and superior vena cava, including time to recurrence and prevalent triggering foci at repeat ablation in patients with paroxysmal atrial fibrillation with or without cardiovascular comorbidities. Methods and Results: A total of 1633 consecutive patients with paroxysmal atrial fibrillation that were arrhythmia‐free for 2 years following the index ablation were classified into: group 1 (without comorbidities); n=692 and group 2 (with comorbidities); n=941. We excluded patients with documented ablation of areas other than pulmonary veins, the left atrial posterior wall, and the superior vena cava at the index procedure. At 10 years after an average of 1.2 procedures, 215 (31%) and 480 (51%) patients had recurrence with median time to recurrence being 7.4 (interquartile interval [IQI] 4.3–8.5) and 5.6 (IQI 3.8–8.3) years in group 1 and 2, respectively. A total of 201 (93.5%) and 456 (95%) patients from group 1 and 2 underwent redo ablation; 147/201 and 414/456 received left atrial appendage and coronary sinus isolation and 54/201 and 42/456 had left atrial lines and flutter ablation. At 2 years after the redo, 134 (91.1%) and 391 (94.4%) patients from group 1 and 2 receiving left atrial appendage/coronary sinus isolation remained arrhythmia‐free whereas sinus rhythm was maintained in 4 (7.4%) and 3 (7.1%) patients in respective groups undergoing empirical lines and flutter ablation ( P <0.001). Conclusions: Very late recurrence of atrial fibrillation after successful isolation of pulmonary veins, regardless of the comorbidity profile, was majorly driven by non‐pulmonary vein triggers and ablation of these foci resulted in high success rate. However, presence of comorbidities was associated with significantly earlier recurrence.

4 May 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
SMSanghamitra Mohanty
Sanghamitra Mohanty
PMPrasant Mohanty
Prasant Mohanty
CTChintan Trivedi
Chintan Trivedi
JAJoanna Assadourian
Joanna Assadourian
AMAngel Quintero Mayedo
Angel Quintero Mayedo
ANAndrea Natale
Andrea Natale
Background: We compared the cognitive status and quality of life in patients with atrial fibrillation undergoing left atrial appendage occlusion (LAAO) or remaining on oral anticoagulation (OAC) after atrial fibrillation ablation. Methods and Results: Cognition was assessed by the Montreal Cognitive Assessment (MoCA) survey at baseline and follow‐up. Consecutive patients receiving LAAO or OAC after atrial fibrillation ablation were screened, and patients with a score of ≤17 were excluded from the study. Quality of life was measured at baseline and 1 year using the Atrial Fibrillation Effect on Quality of Life survey. A total of 50 patients (CHA 2 DS 2 ‐VASc [congestive heart failure, hypertension, age≥75 years, diabetes mellitus, stroke or transient ischemic attack, vascular disease, age 65–74 years, sex category] score: 3.30±1.43) in the LAAO group and 48 (CHA 2 DS 2 ‐VASc score 2.73±1.25) in the OAC group were included in this prospective study. Mean baseline MoCA score was 26.18 and 26.08 in the LAAO and OAC groups, respectively ( P =0.846). At 1 year, scores were 26.94 and 23.38 in the respective groups. MoCA score decreased by an estimated −2.74 (95% CI, −3.61 to −1.87; P <0.0001) points in the OAC group, whereas the change in the LAAO group was nonsignificant (0.79; (95% CI, −0.06 to 1.64; P =0.07). After adjusting for baseline clinical characteristics, remaining on OAC was an independent predictor of MoCA change at 1 year (regression coefficient, −3.38; 95% CI, −4.75 to −2.02; P <0.0001). Change in Atrial Fibrillation Effect on Quality of Life score did not differ significantly in achieving a clinically important difference between groups. Conclusions: In this series, a significant difference in the postprocedure MoCA score was observed in postablation patients with atrial fibrillation receiving LAAO versus remaining on OAC with a substantial decline in the score in the OAC group. However, quality of life improved similarly across groups. Registration: https://www.ClinicalTrials.gov . Unique identifier: NCT01816308

1 October 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
SMSanghamitra Mohanty
Sanghamitra Mohanty
CTChintan Trivedi
Chintan Trivedi
DRDomenico Giovanni. Della Rocca
Domenico Giovanni. Della Rocca
CGCarola Gianni
Carola Gianni
BMBryan MacDonald
Bryan MacDonald
ANAndrea Natale
Andrea Natale
Background: Optimal duration of energy delivery in high-power short-duration (HPSD) ablation to create a durable lesion in atrial fibrillation (AF) is not clear yet. We evaluated the association of electrical reconnection with lesion duration in HPSD-ablation. Methods: HPSD ablation was defined as maximum temperature at 42 °C and power delivery at 45 W for 10 to 15 seconds (5 seconds in coronary sinus [CS] and left atrial posterior wall [LAPW] near the esophagus). In some patients, a mechanical tool was used to deflect the esophagus away from the ablation site. Results: Consecutive 1749 patients with AF (left atrial appendage and CS isolation: 1451) receiving redo ablation after a prior HPSD procedure were included. At the HPSD ablation, mean duration of lesion was significantly shorter in the LAPW facing esophagus compared with elsewhere (5.2±1.5 versus 12.5±1.7 seconds, P <0.001). Application duration was reduced to <10 seconds in 1221 (84%) patients receiving left atrial appendage and CS isolation. At the redo, recovery of conduction was noted in the CS (592, 40.8%), left atrial appendage (493, 34%), and PV and LAPW (249, 14.2%). Of the 249 patients with LAPW reconnection, 91% (n=227) had the conduction recovered in the area facing the esophagus. In 73 patients, esophageal displacement device was used during the HPSD ablation. Average duration of lesions in LAPW among those 73 patients was 9.2±2 seconds. PV-LAPW reconnection was observed in 3/73 (4.1%) patients. Conclusions: HPSD ablation with lesion duration of <10 seconds was associated with conduction recovery in the left atrial appendage, CS, and the LAPW area facing esophagus.

21 March 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
SMSanghamitra Mohanty
Sanghamitra Mohanty
JBJohn D Burkhardt
John D Burkhardt
LBLuigi Di Biase
Luigi Di Biase
PMPrasant Mohanty
Prasant Mohanty
SSSai Shishir Shetty
Sai Shishir Shetty
ANAndrea Natale
Andrea Natale
This study aimed to examine the clinical benefits of targeted ablation of all Premature ventricular complex (PVC) morphologies vs. predominant PVC only. A total of 171 consecutive patients with reduced left ventricular ejection fraction (LVEF) and ≥2 PVC morphology with high burden (>10%/day) undergoing their first ablation procedure were included in the analysis. At the initial procedure, prevalent PVC alone was ablated in the majority. However, at the redo, all PVC morphologies were targeted for ablation. : At the first procedure, 152 (89%) patients received ablation of the dominant PVC only. In the remaining 19 (11%) patients, all PVC morphologies were ablated. At two years, high PVC burden was detected in 89 (52%) patients. Repeat procedure was performed in 78 of 89, where all PVC morphologies were ablated. At 5 years after the repeat procedure, 71 (91%) had PVC burden of <5% [3.8 ± 1.1% vs. 15.4 ± 4.3% in successful vs. failed subjects (P < 0.001)]. In patients with low PVC burden after the initial procedure, LVEF improved from 37.5% to 41.6% [mean difference (MD): 3.39 ± 2.9%, P < 0.001], whereas a reduction in LVEF from 39.8% to 34.5% (MD: 6.45 ± 4.7%, P < 0.001) was recorded in patients with high PVC burden. One year after the repeat procedure, LVEF improved from 36.2% to 41.7% (MD: 5.5 ± 4.3%, P < 0.001) in patients with successful ablation. In this observational series, ablation of all PVC morphologies was associated with significantly lower PVC burden and improvement of LVEF at long-term follow-up, compared with ablation of the dominant morphology only.

1 February 2020 in Heart Rhythm
Verified
Journal Article
Closed access
Ugur CanpolatUgur Canpolat
Ugur Canpolat
SMSanghamitra Mohanty
Sanghamitra Mohanty
CTChintan Trivedi
Chintan Trivedi
QCQiong Chen
Qiong Chen
HAHuseyin Ayhan
Huseyin Ayhan
ANAndrea Natale
Andrea Natale